BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND ERCC4, XPF, 2072, ENSG00000175595, Q92889
12 results:

  • 1. Presumed Pathogenic Germ Line and Somatic Variants in African American thyroid cancer.
    Hurst ZA; Liyanarachchi S; Brock P; He H; Nabhan F; Veloski C; Toland AE; Ringel MD; Jhiang SM
    Thyroid; 2024 Mar; 34(3):378-387. PubMed ID: 38062767
    [No Abstract]    [Full Text] [Related]  

  • 2. DNA Methylation Profiling Distinguishes Adamantinoma-Like Ewing Sarcoma From Conventional Ewing Sarcoma.
    Fritchie KJ; Ameline B; Andrei V; Griffith C; Shah AA; Dermawan JK; Trucco M; Budd T; Thangaiah JJ; Molligan J; Whaley RD; Magliocca K; Azzato E; van Zante A; Jo V; Xu B; Bishop JA; Rooper L; Baumhoer D
    Mod Pathol; 2023 Nov; 36(11):100301. PubMed ID: 37567448
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. xpf -673C>T variation is associated with the susceptibility to breast cancer.
    Wu H; Song Q; Zhang Z; Li A; Zhu X; Yang Z; Zhang X
    Cancer Epidemiol; 2021 Oct; 74():102007. PubMed ID: 34416547
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Rates of Thy 1-non-diagnostic thyroid fine needle aspiration using the UK Royal College of Pathologists Thy Terminology. A systematic review of the literature comparing patients who undergo rapid on-site evaluation and those who do not.
    Poller DN; Doyle V; Trimboli P; Bongiovanni M
    Cytopathology; 2020 Nov; 31(6):502-508. PubMed ID: 32003044
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma.
    Cipollini M; Figlioli G; Maccari G; Garritano S; De Santi C; Melaiu O; Barone E; Bambi F; Ermini S; Pellegrini G; Cristaudo A; Foddis R; Bonotti A; Romei C; Vivaldi A; Agate L; Molinari E; Barale R; Forsti A; Hemminki K; Elisei R; Gemignani F; Landi S
    DNA Repair (Amst); 2016 May; 41():27-31. PubMed ID: 27062014
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Subclinical hypothyroidism as an independent risk factor for colorectal neoplasm.
    Mu G; Mu X; Xing H; Xu R; Sun G; Dong C; Pan Q; Xu C
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):261-6. PubMed ID: 25242140
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer.
    Santos LS; Gomes BC; Gouveia R; Silva SN; Azevedo AP; Camacho V; Manita I; Gil OM; Ferreira TC; Limbert E; Rueff J; Gaspar JF
    Oncol Rep; 2013 Nov; 30(5):2458-66. PubMed ID: 23982724
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Diagnostic value of diffusion-weighted MR imaging in thyroid disease: application in differentiating benign from malignant disease.
    Wu Y; Yue X; Shen W; Du Y; Yuan Y; Tao X; Tang CY
    BMC Med Imaging; 2013 Jul; 13():23. PubMed ID: 23899414
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
    Milos IN; Frank-Raue K; Wohllk N; Maia AL; Pusiol E; Patocs A; Robledo M; Biarnes J; Barontini M; Links TP; de Groot JW; Dvorakova S; Peczkowska M; Rybicki LA; Sullivan M; Raue F; Zosin I; Eng C; Neumann HP
    Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Clinical research on 2228 cases of thyroid gland tumors].
    Wang JD; Deng XC; Jin XJ; Zhou C; Zhang C; Xie M; Zhou JQ; Qian MF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Apr; 40(4):295-9. PubMed ID: 16008266
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Surgeon-performed ultrasound in the management of thyroid malignancy.
    Solorzano CC; Carneiro DM; Ramirez M; Lee TM; Irvin GL
    Am Surg; 2004 Jul; 70(7):576-80; discussion 580-2. PubMed ID: 15279178
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Human kallikrein 2 (hK2) mRNA in peripheral blood of patients with thyroid cancer: a novel molecular marker?
    Roddiger SJ; Renneberg H; Martin T; Tunn UW; Zamboglou N; Kurek R
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):29-34. PubMed ID: 12618898
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.